Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine

Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring

(2013) Thomas Blevins et al.   Endocrine Practice

The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)

(2012) Giovanni Sartore et al.   ACTA DIABETOLOGICA

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes

(2012) R. M. Bergenstal et al.   DIABETES CARE

Does Glycemic Variability Impact Mood and Quality of Life?

(2012) Sue Penckofer et al.   Diabetes Technology & Therapeutics

Use of Continuous Glucose Monitoring as an Outcome Measure in Clinical Trials

(2012) Roy W. Beck et al.   Diabetes Technology & Therapeutics

Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data

(2012) Yongming Qu et al.   Diabetes Technology & Therapeutics

Comparative Effectiveness of Basal-BolusVersusPremix Analog Insulin on Glycemic Variability and Patient-Centered Outcomes during Insulin Intensification in Type 1 and Type 2 Diabetes: A Randomized, Controlled, Crossover Trial

(2012) Marcia A. Testa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

(2011) T. Battelino et al.   DIABETES CARE

The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes

(2011) Louis Monnier et al.   Diabetes Technology & Therapeutics

New and Improved Methods to Characterize Glycemic Variability Using Continuous Glucose Monitoring

(2009) David Rodbard   Diabetes Technology & Therapeutics

Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring

(2009) David Rodbard et al.   Diabetes Technology & Therapeutics